Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
The Massachusetts-focused device industry trade group has appointed journalist Brian Johnson as its new president, replacing long-time leader Tom Sommer.
Kennedy Replacement On Supreme Court Could Impact FDA Preemption Law, Sales Of Contraceptive Devices
President Trump’s promise to replace retiring Justice Anthony Kennedy with a new, more conservative justice could have big implications on the court’s future rulings on a range of device-related issues, from US FDA pre-emption to IUD sales, to Affordable Care Act coverage of devices.
The first of a multi-part Medtech Insight feature series on what a more conservative Supreme Court could mean for future court decisions that impact the medical device industry.
Sandra Peterson is retiring as worldwide chairman of J&J after about five years in the post; several other executives moved up in the ranks.
Gelesis reels in former Walgreens and Boehringer Ingelheim execs as it prepares to take its anti-obesity capsule-based treatment towards regulatory approvals.
Vortex Biosciences has announced two promotions within its top executive team, including naming a new CEO.
Neuromodulation technology specialist SetPoint Medical has appointed Ankit Shah, whose track record include stints at Intersect ENT and Medtronic, as head of commercialization and marketing.
Company stock will make up the "vast majority" of Mike Weinstein's compensation for being Medtronic's new senior VP of strategy. CEO Omar Ishrak said Medtronic's evolving executive compensation policies are an element of the firm's efforts to improve value to shareholders. See what Ishrak said about it here.
Liquid biopsy company Inivata is on the hunt for a new CEO following Michael Stocum's departure.
Weinstein, who has followed the firm extremely closely from his perch as an analyst, says he is very confident about the opportunities that can be leveraged within Medtronic's business, so much so that he is tying most of his salary to company stock.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.